Staphylococcal enterotoxin B (SEB) and related superantigenic toxins are potent stimulators of the immune system and cause a variety of diseases in humans, ranging from food poisoning to toxic shock. These toxins bind directly to major histocompatibility complex (MHC) class II molecules on antigen-presenting cells and specific Vb regions of T-cell receptors (TCR), resulting in hyperactivation of both monocytes/macrophages and T？lymphocytes. Activated host cells produce massive amounts of proinflammatory cytokines and chemokines, activating inflammation and coagulation, causing clinical symptoms that include fever, hypotension, and shock. This review summarizes the in vitro and in vivo effects of staphylococcal superantigens, the role of pivotal mediators induced by these toxins in the pathogenic mechanisms of tissue injury, and the therapeutic agents to mitigate the toxic effects of superantigens.
Fraser, J.D.; Proft, T. The bacterial superantigen and superantigen-like proteins. Immunol. Rev.？2008, 225, 226–243.
[9]
Choi, Y.; Kotzin, B.; Hernon, L.; Callahan, J.; Marrack, P.; Kappler, J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc. Natl. Acad. Sci. USA？1989, 86, 8941–8945.
[10]
Jupin, C.; Anderson, S.; Damais, C.; Alouf, J.E.; Parant, M. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J. Exp. Med.？1988, 167, 752–761.
[11]
Parsonnet, J. Mediators in the pathogenesis of toxic shock syndrome: overview. Rev. Infect. Dis.？1989, 11, S263–S269.
[12]
Fischer, H.; Dohlsten, M.; Andersson, U.; Hedlund, P.; Ericsson, P.; Hansson, J.; Sjogren, H.O. Production of TNF-α and TNF-β by staphylococcal enterotoxin A activated human T cells. J. Immunol.？1990, 144, 4663–4668.
[13]
Trede, N.S.; Geha, R.S.; Chatila, T. Transcriptional activation of IL-1 beta and tumor necrosis factor-alpha genes by MHC class II ligands. J. Immunol.？1991, 146, 2310–2315.
[14]
See, R.H.; Kum, W.W.; Chang, A.H.; Goh, S.H.; Chow, A.W. Induction of tumor necrosis factor and interleukin-1 by purified staphylococcal toxic shock syndrome toxin 1 requires the presence of both monocytes and T lymphocytes. Infect. Immun.？1992, 60, 2612–2618. 1612731
[15]
Krakauer, T. Inhibition of toxic shock syndrome toxin-induced cytokine production and T cell activation by interleukin 10, interleukin 4, and dexamethasone. J. Infect. Dis.？1995, 172, 988–992.
[16]
Tessier, P.A.; Naccache, P.H.; Diener, K.R.; Gladue, R.P.; Neotem, K.S.; Clark-Lewis, I.; McColl, S.R. Induction of acute inflammation in vivo by staphylococcal superantigens. II. Critical role for chemokines, ICAM-1, and TNF-alpha. J. Immunol.？1998, 161, 1204–1211. 9686580
[17]
Krakauer, T. The induction of CC Chemokines in human peripheral blood mononuclear cells by staphylococcal exotoxins and its prevention by pentoxifylline. J. Leukco. Biol.？1999, 66, 158–164.
[18]
Krakauer, T. Immune response to staphylococcal superantigens. Immunol. Res.？1999, 20, 163–173.
[19]
Mattsson, E.; Herwald, H.; Egsten, A. Superantigen from Staphylococcus aureus induce procoagulant activity and monocyte tissue factor expression in whole blood and mononuclear cells via IL-1β. J. Thromb. Haemost.？2003, 1, 2569–2575.
[20]
Krakauer, T.; Vilcek, J.; Oppenheim, J.J. Proinflammatory cytokines: TNF and IL-1 families, chemokines, TGF？ and others. In Fundamental Immunology, 4th; Paul, W., Ed.; Lippincott-Raven: Philadelphia, PA, USA, 1998; pp. 775–811.
[21]
Vial, T.; Descotes, J. Immune-mediated side-effects of cytokines in human. Toxicology？1995, 105, 31–57.
[22]
Papageorgiou, A.C.; Acharya, K.R. Microbial superantigens: from structure to function. Trends Microbiol.？2000, 8, 369–375.
[23]
Monday, S.R.; Bohach, G.A. Properties of Staphylococcus aureus enterotoxins and toxic shock syndrome toxin-1. In The Comprehensive Sourcebook of Bacterial Protein Toxins; Alouf, J.E., Freer, J.H., Eds.; Academic: London, UK, 1999; pp. 589–610.
[24]
Kappler, J.W.; Herman, A.; Clements, J.; Marrack, P. Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J. Exp. Med.？1992, 175, 387–396.
[25]
Holmberg, S.D.; Blake, P.A. Staphylococcal food poisoning in the United States. New facts and old misconceptions. JAMA？1984, 251, 487–489. 6690814
[26]
Abdelnour, A.T.; Bremell, T.; Tarkowski, A. TSST-1 contributes to the arthritogenecity of Staphylococcus aureus. J. Infect. Dis.？1994, 170, 94–99.
[27]
Schwab, J.H.; Brown, R.R.; Anderle, S.K.; Schlievert, P.M. Superantigen can reactivate bacterial cell wall-induced arthritis. J. Immunol.？1993, 150, 4151–4159.
[28]
Brocke, S.; Hausmann, S.; Steinmam, L.; Wucherpfennig, K.W. Microbial peptides and superantigens in the pathogenesis of autoimmune diseases of the central nervous system. Semin. Immunol.？1998, 10, 57–67.
[29]
Yarwood, J.M.; Leung, D.Y.; Schlievert, P.M. Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome. FEMS Microbiol. Lett.？2000, 192, 1–7.
[30]
Origuchi, T.; Eguchi, K.; Kawabe, Y.; Yamashita, I.; Mizokami, A.; Ida, H.; Nagataki, S. Increased levels of serum IgM antibody to staphylococcal enterotoxin B in patients with rheumatoid arthritis. Ann. Rheum. Dis.？1995, 54, 713–732.
[31]
Meissner, H.C.; Leung, D.Y.M. Superantigens, conventional antigens and the etiology of Kawasaki syndrome. Pediatr. Infect. Dis. J.？2000, 19, 91–94.
[32]
Meissner, H.C.; Leung, D.Y.M. Kawasaki Syndrome: Where Are the Answers? Pediatrics？2003, 112, 672–676, doi:10.1542/peds.112.3.672. 12949301
[33]
Mollick, J.A.; Chintagumpala, M.; Cook, R.G.; Rich, R.R. Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype. J. Immunol.？1991, 146, 463–468. 1987273
[34]
Herrmann, T.; Acolla, R.S.; MacDonald, H.R. Different staphylococcal enterotoxins bind preferentially to distinct MHC class II isotypes. Eur. J. Immunol.？1989, 19, 2171–2174.
[35]
Herman, A.; Croteau, G.; Sekaly, R.P.; Kappler, J.; Marrack, P. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J. Exp. Med.？1990, 172, 709–712.
[36]
Chintagumpala, M.M.; Mollick, J.A.; Rich, R.R. Staphylococcal toxins bind to different sites on HLA-DR. J. Immunol.？1991, 147, 3876–3882.
[37]
Scholl, P.; Sekaly, R.; Diez, A.; Glimcher, L.; Geha, R. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules. Eur. J. Immunol.？1990, 20, 1911–1916.
[38]
Thibodeau, J.; Cloutier, I.; Lavoie, P.M.; Labrecque, N.; Mourad, W.; Jardetzky, T.; Sekaly, R.P. Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding. Science？1994, 266, 1874–1878.
[39]
Ulrich, R.G.; Bavari, B.; Olson, M.A. Staphylococcal enterotoxins A and B share a common structural motif for binding class II major histocompatibility complex molecules. Nat. Struct. Biol.？1995, 2, 554–560.
[40]
Hudson, K.R.; Tiedemann, R.E.; Urban, R.G.; Lowe, S.C.; Strominger, J.L.; Fraser, J.D. Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II. J. Exp. Med.？1995, 182, 711–720.
[41]
Tiedemann, R.E; Urban, R.J.; Strominger, J.L.; Fraser, J.D. Isolation of HLA-DR1.(staphylococcal enterotoxins A)2 trimers in solution. Proc. Natl. Acad. Sci. USA？1995, 92, 12156–12159, doi:10.1073/pnas.92.26.12156.
[42]
Pless, D.D.; Ruthel, G.; Reinke, E.K.; Ulrich, R.G.; Bavari, S. Persistence of zinc-binding bacterial superantigens at the surface of antigen-presenting cells contributes to the extreme potency of these superantigens as T-cell activators. Infect. Immun.？2005, 73, 5358–5366.
[43]
Linsley, P.S.; Ledbetter, J.A. The role of the CD28 receptor during T cell responses to antigen. Ann. Rev. Immunol.？1993, 11, 191–212.
[44]
Fraser, J.; Newton, M.; Weiss, A. CD28 and T-cell antigen receptor signal transduction coordinately regulates interleukin 2 gene expression in response to superantigen stimulation. J. Exp. Med.？1992, 175, 1131–1134.
[45]
Krakauer, T. Costimulatory receptors for the superantigen staphyloccoccal enterotoxin B on human vascular endothelial cells and T cells. J. Leukco. Biol.？1994, 56, 458–463.
[46]
Mehindate, K.; al-Daccak, R.; Damdoumi, F.; Mourad, W. Synergistic effect between CD40 and class II signals overcomes the requirement for class II dimerization in superantigen-induced cytokine gene expression. Eur.J. Immunol.？1996, 26, 2075–2080.
[47]
Saha, B.; Jaklic, B.; Harlan, D.M.; Gray, G.S.; June, C.H.; Abe, R. Toxic shock syndrome toxin-1 induced death is prevented by CTLA4Ig. J. Immunol.？1996, 157, 3869–3875.
[48]
Carlsson, R.; Fischer, H.; Sjogren, H.O. Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J. Immunol.？1998, 140, 2484–2488.
[49]
Tiedemann, R.E.; Fraser, J.D. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation. J. Immunol.？1996, 157, 3958–3966.
[50]
Anderson, M.R.; Tary-Lehmann, M. Staphylococcal enterotoxin-B-induced lethal shock in mice is T-cell-dependent, but disease susceptibility is defined by the non-T-cell compartment. Clin. Immunol.？2001, 98, 85–94.
[51]
Chatila, T.; Geha, R.S. Signal transduction by microbial superantigens via MHC class II molecules. Immunol. Rev.？1993, 131, 43–59.
[52]
Chatila, T.; Wood, N.; Parsonnet, J.; Geha, R.S. Toxic shock syndrome toxin-1 induces inositol phospholipid turnover, protein kinase C translocation, and calcium mobilization in human T cells. J. Immunol.？1988, 140, 1250–1255.
[53]
Scholl, P.R.; Trede, N.; Chatila, T.A.; Geha, R.S. Role of protein tyrosine phosphorylation in monokine induction by the staphylococcal superantigen toxic shock syndrome toxin-1. J. Immunol.？1992, 148, 2237–2241.
[54]
Krakauer, T. Small nonpeptide inhibitors of staphylococcal superantigen-induced cytokine production and toxic shock. In Superantigens: Molecular Basis for Their Role in Human Diseases; Kotb, M., Fraser, J.D., Eds.; ASM: Washington, DC, USA, 2007; pp. 229–224.
[55]
Hewitt, C.; Lamb, J.; Hayball, J.; Hill, M.; Owen, M.; O’Hehir, R. MHC Independent clonal T cell anergy by direct interaction of staphylococcal enterotoxin B with the T-cell antigen receptor. J. Exp. Med.？1992, 175, 1493–1499.
[56]
Scheuber, P.H.; Denzlinger, C.; Wilker, D.; Beck, G.; Kepper, D.; Hammer, D.K. Staphylococcal enterotoxin B as a nonimmunological mast cell stimulus in primates: the role of endogenous cysteinyl leukotrienes. Int. Arch. Allergy Appl. Immunol.？1987, 82, 289–291.
[57]
Mourad, W.; Mehindate, K.; Schall, T.; McColl, S. Engagement of MHC class II molecules by superantigen induces inflammatory cytokine gene expression in human rheumatoid fibroblast-like synoviocytes. J. Exp. Med.？1992, 175, 613–616.
[58]
Hamad, A.R.; Marrack, P.; Kappler, J.W. Transcytosis of staphylococcal superantigen toxins. J. Exp. Med.？1997, 185, 1447–1454.
[59]
Peterson, M.L.; Ault, K.; Kremer, M.J.; Klingelhutz, A.J.; Davis, C.C.; Squier, C.A.; Schlievert, P.M. The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1. Infect. Immun.？2005, 73, 2164–2174.
[60]
McKay, D.M. Bacterial superantigens: provocateurs of gut dysfunction and inflammation? Trends Immunol.？2001, 22, 497–501.
[61]
Krakauer, T. Stimulant-dependent modulation of cytokines and chemokines by airway epithelial cells: cross- talk between pulmonary epithelial and peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol.？2002, 9, 126–131.
[62]
Shupp, J.W.; Jett, M.; Pontzer, C.H. Identification of a transcytosis epitope on staphylococcal enterotoxins. Infect. Immun.？2002, 1029, 313–318.
[63]
Pinchuk, I.V.; Beswick, E.J.; Saada, J.I.; Suarez, G.; Winston, J.; Mifflin, R.C.; Di Mari, J.F.; Powell, D.W.; Reyes, V.E. Monocyte chemoattractant protein-1 production by intestinal myofibroblasts in response to staphylococcal enterotoxin A: relevance to staphylococcal enterotoxigenic disease. J. Immunol.？2007, 178, 8097–8106.
[64]
Takeuchi, O.; Akira, S. Pattern recognition receptors and inflammation. Cell？2010, 140, 805–820.
[65]
Vallabhapurapu, S.; Karin, M. Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol.？2009, 27, 693–733.
[66]
Krakauer, T. Molecular therapeutic targets in inflammation: cyclooxygenase and NF-κB. Curr. Drug Targets Inflamm. Allergy？2004, 3, 317–324.
[67]
Keystone, E.C.; Ware, C.F. Tumor necrosis factor and anti-tumor necrosis factor therapies. J. Rheumatol.？2010, 85, 27–39.
[68]
Dunn, G.P.; Koebel, C.M.; Schreiber, R.D. Interferons, immunity and cancer immunoediting. Nat. Rev. Immunol.？2006, 6, 836–848.
Luster, A.D.; Alon, R.; von Andrian, U.H. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol.？2005, 6, 1182–1190.
[71]
Neumann, B.; Engelhardt, B.; Wagner, H.; Holzmann, B. Induction of acute inflammatory lung injury by staphylococcal enterotoxin B. J. Immunol.？1997, 158, 1862–1871.
[72]
Krakauer, T.; Buckley, M.; Huzella, L.M.; Alves, D. Critical timing, location and duration of glucocorticoid administration rescues mice from superantigen-induced shock and attenuates lung injury. Int. Immunopharmacol.？2009, 9, 1168–1174.
[73]
Ettinger, R.; Panka, D.J.; Wang, J.K.; Stanger, B.Z.; Ju, S.T.; Marshak-Rothstein, A. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen. J. Immunol.？1995, 154, 4302–4308.
Sriskandan, S.; Unnikrishnan, M.; Krausz, T.; Dewchand, H.; Van Noorden, S.; Cohen, J.; Altmann, D.M. Enhanced susceptibility to superantigen-associated streptococcal sepsis in human leukocyte antigen-DQ transgenic mice. J. Infect. Dis.？2001, 184, 166–173.
[76]
Krakauer, T.; Pitt, L.; Hunt, R.E. Detection of IL-6 and IL-2 in serum of rhesus monkeys exposed to a nonlethal dose of staphylococcal enterotoxin B. Mil. Med.？1997, 162, 612–615.
Goettelfinger, P.; Lecerf, F.; Berrih-Aknin, S.; German-Fattal, M. Cytokine deviation induced by intrathymic injection of staphylococcal enterotoxin B (SEB). Eur. Cytokine Netw.？2001, 12, 487–500.
[79]
Huzella, L.M.; Buckley, M.J.; Alves, D.A.; Stiles, B.G.; Krakauer, T. Central roles for IL-2 and MCP-1 following intranasal exposure to SEB: A new mouse model. Vet. Res. Sci.？2009, 86, 241–247.
[80]
Hodoval, L.F.; Morris, E.L.; Crawley, G.J.; Beisel, W.R. Pathogenesis of lethal shock after intravenous staphylococcal enterotoxin B in monkeys. Appl. Microbiol.？1968, 16, 187–192.
[81]
Spiekermann, G.M.; Nagler-Anderson, C. Oral adminstration of the bacterial superantigen staphylococcal enterotoxin B induces activation and cytokine production by T cells in murine gut-associated lymphoid tissue. J. Immunol.？1998, 161, 5825–5831.
[82]
Alber, G.; Scheuber, P.H.; Reck, B.; Sailer-Kramer, B.; Hartmann, A.; Krammer, D.K. Role of substance P in immediate-type skin reactions induced by staphylococcal enterotoxin B in unsensitized monkeys. J. Allergy Clin. Immunol.？1998, 84, 880–885.
[83]
Hu, D.L.; Zhu, G.; Mori, F.; Omoe, K.; Okada, M.; Wakabayashi, K.; Kaneko, S.; Shinagawa, K.; Nakane, A. Staphylococcal enterotoxin induces emesis through increasing serotonin release in intestine and it is downregulated by cannabinoid receptor 1. Cell Microbiol.？2007, 9, 2267–2277.
[84]
Stiles, B.G.; Bavari, S.; Krakauer, T.; Ulrich, R.G. Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release. Infect. Immun.？1993, 61, 5333–5338.
[85]
Sugiyama, H.; McKissic, E.M.; Bergdoll, M.S.; Heller, B. Enhancement of bacterial endotoxin lethality by staphylococcal enterotoxin. J. Infect. Dis.？1964, 4, 111–118.
[86]
Miethke, T.; Wahl, C.; Heeg, K.; Echtenacher, B.; Krammer, P.H.; Wagner, H. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med.？1992, 175, 91–98.
Sarawar, S.R.; Blackman, B.A.; Doherty, P.C. Superantigen shock in mice with an inapparent viral infection. J. Infect. Dis.？1994, 170, 1189–1194.
[89]
Chen, J.Y.; Qiao, Y.; Komisar, J.L.; Baze, W.B.; Hsu, I.C.; Tseng, J. Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D. Infect. Immun.？1994, 62, 4626–4631.
[90]
Zhang, W.J.; Sarawar, S.; Nguyen, P.; Daly, K.; Rehig, J.E.; Doherty, P.C.; Woodland, D.L.; Blackman, M.A. Lethal synergism between influenza infection and staphylococcal enterotoxin B in mice. J. Immunol.？1996, 157, 5049–5060. 8943414
[91]
Blank, C.; Luz, A.; Bendigs, S.; Erdmann, A.; Wagner, H.; Heeg, K. Superantigen and endotoxin synergize in the induction of lethal shock. Eur. J. Immunol.？1997, 27, 825–833.
[92]
Khan, A.A.; Priya, S.; Saha, B. IL-2 regulates SEB induced toxic shock syndrome in BALB/c mice. PLoS One？2009, 4, e8473.
[93]
Matthys, P.; Mitera, T.; Heremans, H.; Van Damme, J.; Billiau, A. Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice. Infect. Immun.？1995, 63, 1158–1164.
[94]
LeClaire, R.D.; Kell, W.; Bavari, S.; Smith, T.; Hunt, R.E. Protective effects of niacinamide in staphylococcal enterotoxin B induced toxicity. Toxicology？1996, 107, 69–81.
Hale, M.L.; Margolin, S.B.; Krakauer, T.; Roy, C.J.; Stiles, B.G. Pirfenidone blocks in vitro and in vivo effects of staphylococcal enterotoxin B. Infect. Immun.？2002, 70, 2989–2994, doi:10.1128/IAI.70.6.2989-2994.2002. 12010989
[97]
Krakauer, T.; Buckley, M. Dexamethasone attenuates staphylococcal enterotoxin B-induced hypothermic response and protects mice from superantigen-induced toxic shock. Antimicrob. Agents Chemother.？2006, 50, 391–395.
[98]
Krakauer, T.; Buckley, M.; Fisher, D. Proinflammatory mediators of toxic shock and their Correlation to lethality. Mediators Inflamm.？2010.
Florquin, S.; Amraoui, Z.; Abramowicz, D.; Goldman, M. Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J. Immunol.？1994, 153, 2618–2623.
[101]
Sundstedt, A.; Hoiden, L.; Rosendahl, A.; Kalland, T.; van Rooijen, N.; Dohlsten, M. Immunoregulatory role of IL-10 during superantigen-induced-hyporesponsiveness in vivo. J. Immunol.？1997, 158, 180–186.
[102]
Miller, C.; Ragheb, J.; Schwartz, R. Anergy and cytokine-mediated suppression as distinct superantigen-induced tolerance mechanisms in vivo. J. Exp. Med.？1999, 190, 53–64.
[103]
McCormack, J.E.; Callahan, J.E.; Kappler, J.; Marrack, P. Profound deletion of mature T cells in vivo by chronic exposure to endogenous superantigen. J. Immunol.？1993, 150, 3785–3792.
[104]
DaSilva, L.; Welcher, B.; Ulrich, R.; Aman, J.; David, C.S.; Bavari, S. Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylocococal enterotoxins: a novel model for superantigen vaccines. J. Infect. Dis.？2002, 185, 1754–1760.
[105]
Rajagopalan, G.; Sen, M.M.; David, C.S. In vitro and in vivo evaluation of staphylococcal superantigen peptide antagonists. Infect. Immun.？2004, 72, 6733–6737.
[106]
Roy, C.J.; Warfield, K.L.; Welcher, B.C.; Gonzales, R.F.; Larsen, T.; Hanson, J.; David, C.S.; Krakauer, T.; Bavari, S. Human leukocyte antigen-DQ8 transgenic mice: a model to examine the toxicity of aerosolized staphylococcal enterotoxin B. Infect. Immun.？2005, 73, 2452–2460.
[107]
Yeung, R.S.; Penninger, J.M.; Kundig, J.; Khoo, W.; Ohashi, P.S.; Kroemer, G.; Mak, T.W. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock. Eur.J. Immun.？1996, 26, 1074–1082.
[108]
Savransky, V.; Rostaphshov, V.; Pinelis, D.; Polotsky, Y.; Korolev, S.; Komisar, J.; Fegeding, K. Murine lethal toxic shock caused by intranasal administration of staphylococcal enterotoxin B. Toxicol. Pathol.？2003, 31, 373–378.
[109]
Stebbings, R.; Findlay, L.; Edwards, C.; Eastwood, D.; Bird, C.; North, D.; Mistry, Y.; Dilger, P.; Liefooghe, E.; Cludts, I.; et al. "Cytokine Storm" in the Phase I Trial of Monoclonal Antibody TGN1412: Better Understanding the Causes to Improve PreClinical Testing of Immunotherapeutics. J. Immunol.？2007, 179, 3325–3331. 17709549
[110]
Darenberg, J.; Soderquist, B.; Normark, B.H.; Norrby-Teglund, A. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. Clin. Infect. Dis.？2004, 38, 836–842, doi:10.1086/381979. 14999628
[111]
Bavari, S.; Ulrich, R.G.; LeClaire, R.D. Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens. J. Infect. Dis.？1999, 180, 1365–1369.
[112]
Bavari, S.; Dyas, B.; Ulrich, R.G. Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A. J. Infect. Dis.？1996, 174, 338–345.
[113]
Arad, G.; Levy, R.; Hillman, D.; Kaempfer, R. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Nat. Med.？2000, 6, 414–421.
[114]
Visvanathan, K.; Charles, A.; Bannan, J.; Pugach, P.; Kashfi, K.; Zabriskie, J.B. Inhibition of bacterial superantigens by peptides and antibodies. Infect. Immun.？2001, 69, 875–884.
[115]
Wang, S.; Li, Y.; Xiong, H.; Cao, J. A broad-spectrum inhibitory peptide against staphylococcal enterotoxin superantigen SEA, SEB and SEC. Immunol. Lett.？2008, 121, 167–172.
[116]
Geller-Hong, E.; M？llhoff, M.; Shiflett, P.R.; Gupta, G. Design of chimeric receptor mimics with different TcRVβ isoforms: type-specific inhibition of superantigen pathogenesis. J. Biol. Chem.？2004, 279, 5676–5684.
[117]
Rasooly, R.; Do, P.M.; Friedman, M. Inhibition of biological activity of staphylococcal enterotoxin A (SEA) by apple juice and apple polyphenols. J. Agric. Food Chem.？2010, 58, 5421–5426.
[118]
Liu, D.; Liu, X.Y.; Robinson, D.; Burnett, C.; Jackson, C.; Seele, L.; Veach, R.A.; Downs, S.; Collins, R.D.; Ballard, R.W.; Hawiger, J. Suppression of staphylococcal enterotoxin B-induced toxicity by a nuclear import inhibitor. J. Biol. Chem.？2004, 279, 19239–19246.
[119]
Liu, D.; Zienkiewicz, J.; DiGiandomenico, A.; Hawiger, J. Suppression of acute lung inflammation by intracellular peptide delivery of a nuclear import inhibitor. Mol. Ther.？2009, 17, 796–802.
[120]
Tilahun, A.Y.; Theuer, J.E.; Patel, R.; David, C.S.; Rajagopalan, G. Detrimental Effect of the Proteasome Inhibitor, Bortezomib in Bacterial Superantigen- and Lipopolysaccharide-induced Systemic Inflammation. Mol. Ther.？2010, 18, 1143–1154.
[121]
Krakauer, T. A sensitive ELISA for measuring the adhesion of leukocytic cells to human endothelial cells. J. Immunol. Meth.？1994, 177, 207–213.
[122]
See, R.H.; Chow, A.W. Staphylococcal toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1？ secretion by human peripheral blood monocytes and T lymphocytes is differentially suppressed by protein kinase inhibitors. Infect. Immun.？1992, 60, 3456–3459.
[123]
Krakauer, T. Suppression of endotoxin- and staphylococcal exotoxin-induced cytokines and chemokines by a phospholipase C inhibitor in human peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol.？2001, 8, 449–453.
[124]
Tschaikowsky, K.J.; Schmidt, J.; Meisner, M. Modulation of mouse endotoxin shock by inhibition of phosphatidylcholine-specific phospholipase C. J. Pharmacol. Exp. Therap.？1999, 285, 800–804.
[125]
Krakauer, T.; Buckley, M.; Issaq, H.J.; Fox, S.D. Rapamycin protects mice from staphylococcal enterotoxin B- induced toxic shock and blocks cytokine release In vitro and in vivo. Antimicrob. Agents Chemother.？2010, 54, 1125–1131.
[126]
Flechner, S.M. Sirolimus in kidney transplantation indications and practical guidelines: de novo sirolimus-based therapy without calcineurin inhibitors. Transplantation？2009, 97, S1–S6.
[127]
Krakauer, T. Caspase inhibitors attenuate superantigen-induced inflammatory cytokines, chemokines and T-cell proliferation. Clin. Diagn. Lab. Immunol.？2004, 11, 621–624.
[128]
Krakauer, T.; Buckley, M. Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines. Antimicrob. Agents Chemother.？2003, 47, 3630–3633.
[129]
Jo, D.; Liu, D.; Yao, S.; Collins, R.D.; Hawiger, J. Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat. Med.？2005, 11, 892–898.
